# An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

> **NCT07543120** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 323 (estimated)

## Conditions studied

- Hypertension (HTN)

## Interventions

- **DRUG:** QCZ484

## Key facts

- **NCT ID:** NCT07543120
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2031-05-31
- **Final completion:** 2031-11-30
- **Target enrollment:** 323 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07543120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07543120, "An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07543120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*